文献速递儿童内分泌与遗传代谢

1990至2019年全球儿童糖尿病流行病学分析

Global, Regional, and National Epidemiology of Diabetes in Children From 1990 to 2019.
PubMed 文献 · JAMA Pediatr · 2023-01-01

该横断面研究基于GBD 2019数据,分析204个国家0-14岁儿童糖尿病发病率、死亡率及DALYs趋势。

要点

  • 1990-2019年儿童糖尿病病例数增加39.37%,全球发病率上升。
  • 全球糖尿病相关死亡率下降,但低SDI地区死亡率最高。
  • 北非和中东发病率增幅最大,芬兰发病率最高,孟加拉死亡率最高。

核心结论

  • 儿童糖尿病是日益严峻的全球健康挑战,发病率持续上升。
  • 尽管全球死亡和DALYs下降,但糖尿病儿童死亡和DALYs数量仍高,尤其低SDI地区。

研究设计与样本

  • 横断面研究,使用GBD 2019数据,覆盖204个国家和地区0-14岁儿童。
  • 分析1990至2019年糖尿病发病率、死亡率和DALYs趋势,按地区、国家、年龄、性别和SDI分层。

主要发现

  • 糖尿病相关死亡从6719(95%UI 4823-8074)降至5390(95%UI 4450-6507)。
  • 全球发病率从9.31(95%UI 6.56-12.57)升至11.61(95%UI 7.98-15.98)/10万,死亡率从0.38(95%UI 0.27-0.46)降至0.28(95%UI 0.23-0.33)/10万。
  • 低SDI地区2019年儿童糖尿病相关死亡率最高。
  • 北非和中东发病率增幅最大(EAPC 2.06,95%CI 1.94-2.17)。

关键数值与推荐

  • 2019年芬兰儿童糖尿病发病率最高(31.60/10万,95%UI 22.65-40.36)。
  • 孟加拉糖尿病相关死亡率最高(1.16/10万,95%UI 0.51-1.70)。
  • 坦桑尼亚DALYs率最高(100.16/10万,95%UI 63.01-155.88)。
  • 环境/职业风险、非适宜温度、高温和低温是2019年儿童糖尿病相关死亡的关键风险因素。

临床怎么用

  • 提示临床医生关注儿童糖尿病发病率上升趋势,尤其在低SDI地区加强死亡预防。
  • 环境温度等风险因素应纳入糖尿病儿童综合管理考量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Diabetes in children is a global epidemic that causes various medical conditions associated with an increased incidence of premature death. OBJECTIVE: To investigate the trends in diabetes incidence, mortality, and disability-adjusted life-years (DALYs) in children, with risk factors for diabetes-associated death, from 1990 to 2019. DESIGN, SETTING, AND PARTICIPANTS: This was a cross-sectional study that used data from the Global Burden of Diseases (GBD) 2019 in 204 countries and territories. Children with diabetes who were aged 0 to 14 years were included in the analysis. Data were analyzed from December 28, 2022, to January 10, 2023. EXPOSURE: Childhood diabetes from 1990 to 2019. MAIN OUTCOME MEASURES: Incidence, all-cause and cause-specific deaths, DALYs, and corresponding estimated annual percentage changes (EAPCs). These trends were stratified according to region, country, age, sex, and Sociodemographic Index (SDI). RESULTS: A total of 1 449 897 children (738 923 male [50.96%]) were included in the analysis. In 2019, there were 227 580 incident cases of childhood diabetes worldwide. Cases of childhood diabetes increased by 39.37% (95% uncertainty interval [UI], 30.99%-45.45%) from 1990 to 2019. Over 3 decades, diabetes-associated deaths decreased from 6719 (95% UI, 4823-8074) to 5390 (95% UI, 4450-6507). The global incidence rate increased from 9.31 (95% UI, 6.56-12.57) to 11.61 (95% UI, 7.98-15.98) per 100 000 population; however, the diabetes-associated death rate decreased from 0.38 (95% UI, 0.27-0.46) to 0.28 (95% UI, 0.23-0.33) per 100 000 population. Among the 5 SDI regions, the low SDI region had the highest childhood diabetes-associated mortality rate in 2019. Regionally, North Africa and the Middle East had the largest increase in incidence (EAPC, 2.06; 95% CI, 1.94-2.17). Among 204 countries, Finland had the highest national incidence of childhood diabetes in 2019 (31.60 per 100 000 population; 95% UI, 22.65-40.36), Bangladesh had the highest diabetes-associated mortality rate (1.16 per 100 000 population; 95% UI, 0.51-1.70), and the United Republic of Tanzania had the highest DALYs rate (100.16 per 100 000 population; 95% UI, 63.01-155.88). Globally, environmental/occupational risk, nonoptimal temperature, high temperature, and low temperature were key risk factors for childhood diabetes-associated mortality in 2019. CONCLUSIONS AND RELEVANCE: Childhood diabetes is an increasing global health challenge with rising incidence. Results of this cross-sectional study suggest that despite the global decline in deaths and DALYs, the number of deaths and DALYs remains high among children with diabetes, especially in low SDI regions. Improved understanding of the epidemiology of diabetes in children may facilitate prevention and control.

来源:JAMA Pediatr,查看原文。版权归原作者所有。

引用

  1. Zhang K, Kan C, Han F, et al. Global, Regional, and National Epidemiology of Diabetes in Children From 1990 to 2019. JAMA Pediatr. 2023. PMID: 37399036. doi:10.1001/jamapediatrics.2023.2029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。